Neurology®
The most widely read and highly cited peer-reviewed Neurology journal
Quick Search
Advanced Search
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Alexopoulos, A.
Right arrow Articles by Wyllie, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Alexopoulos, A.
Right arrow Articles by Wyllie, E.
Related Collections
Right arrow All Clinical trials
Right arrow All Epilepsy/Seizures
Right arrow Epilepsy monitoring
Right arrow Epilepsy surgery
NEUROLOGY 2005;64:567-570
© 2005 American Academy of Neurology
Brief Communications

Resective surgery to treat refractory status epilepticus in children with focal epileptogenesis

A. Alexopoulos, MD, D. K. Lachhwani, MD, A. Gupta, MD, P. Kotagal, MD, A. M. Harrison, MD, W. Bingaman, MD and E. Wyllie, MD

From the Departments of Neurology (Drs. Alexopoulos, Lachhwani, Gupta, Kotagal, and Wyllie), Pediatric Critical Care Medicine (Dr. Harrison), and Neurosurgery (Dr. Bingaman), The Cleveland Clinic Foundation, Cleveland, OH.

Address correspondence and reprint requests to Dr. Deepak K. Lachhwani, Section of Pediatric Epilepsy and Pediatric Neurology, The Cleveland Clinic Foundation, 9500 Euclid Avenue, S-51, Cleveland, OH 44195; e-mail: lachhwd{at}ccf.org

Prolonged high-dose suppressive therapy (HDST) is a mainstay in the management of refractory status epilepticus (RSE), albeit with high morbidity and mortality. The authors studied 10 patients who were carefully selected for epilepsy surgery after failing prolonged (>2 weeks) HDST. Status epilepticus was stopped acutely in all of them with no mortality and no substantial morbidity. At follow-up (median 7 months), 7 (70%) of 10 patients were seizure free, and 3 (30%) of 10 had significant improvement in their epilepsy.

Received April 30, 2004. Accepted in final form September 15, 2004.




This article has been cited by other articles:


Home page
 J Intensive Care MedHome page
D. J. Costello and A. J. Cole
Treatment of Acute Seizures and Status Epilepticus
J Intensive Care Med, November 1, 2007; 22(6): 319 - 347.
[Abstract] [PDF]

Home page
 NeurologyHome page
E. Wyllie, D. K. Lachhwani, A. Gupta, A. Chirla, G. Cosmo, S. Worley, P. Kotagal, P. Ruggieri, and W. E. Bingaman
Successful surgery for epilepsy due to early brain lesions despite generalized EEG findings
Neurology, July 24, 2007; 69(4): 389 - 397.
[Abstract] [Full Text] [PDF]

Home page
 J Child NeurolHome page
I. S. Mohamed, H. Otsubo, K. Imai, M. Shroff, R. Sharma, S. H. Chuang, E. Donner, J. Drake, and O. C. Snead III
Surgical Treatment for Acute Symptomatic Refractory Status Epilepticus: A Case Report
J Child Neurol, April 1, 2007; 22(4): 435 - 439.
[Abstract] [PDF]

Home page
 Arch NeurolHome page
D. J. Costello, M. V. Simon, E. N. Eskandar, M. P. Frosch, H. L. Henninger, K. H. Chiappa, and A. J. Cole
Efficacy of surgical treatment of de novo, adult-onset, cryptogenic, refractory focal status epilepticus.
Arch Neurol, June 1, 2006; 63(6): 895 - 901.
[Abstract] [Full Text] [PDF]